SAN JOSE, Calif., Aug 24 (Bernama) -- Shape Memory Medical Inc., developer of proprietary shape memory polymer technology for endovascular embolization, today announced the closing of a $10 million convertible note financing led by new investor August Global Partners (AGP), joined by fellow new investor Taiwania Capital.
The financing provides capital to support continued clinical development of the company’s aortic portfolio, including patient follow-up and data collection in the AAA-SHAPE Pivotal Trial, and advancement of the FLAGSHIP feasibility trial. Shape Memory Medical is backed by a global syndicate of healthcare investors that includes HBM Healthcare Investments (Cayman) Ltd., Earlybird Venture Capital, and WexMed II, LLC.